Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
1.790
-0.020 (-1.10%)
May 28, 2026, 1:59 PM EDT - Market open

Cardiff Oncology Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8.5417.4751.4721.6616.3511.94
Short-Term Investments
37.5140.8340.2853.1788.92128.88
Cash & Short-Term Investments
46.0658.391.7574.82105.27140.82
Cash Growth
-42.35%-36.45%22.62%-28.92%-25.25%7.51%
Accounts Receivable
0.190.180.770.290.770.54
Other Current Assets
1.11.642.542.35.254.77
Total Current Assets
47.3460.1395.0577.41111.28146.13
Net Property, Plant & Equipment
0.991.212.072.953.523.18
Other Long-Term Assets
0.840.550.071.281.390.24
Total Assets
49.1761.8897.1981.64116.19149.54
Accounts Payable
5.488.094.821.971.961.44
Accrued Expenses
8.347.587.97.785.184.53
Current Portion of Leases
0.650.730.710.690.680.55
Other Current Liabilities
-----0.04
Total Current Liabilities
14.4616.3913.4310.447.816.56
Long-Term Leases
-0.10.811.462.042.57
Total Long-Term Liabilities
-0.10.811.462.042.57
Total Liabilities
14.4616.514.2411.99.859.13
Preferred Stock
-----0
Common Stock
0.010.010.01000
Additional Paid-in Capital
477.13475.36467.09409.34404.83400.5
Accumulated Other Comprehensive Income
-0.050.050.03-0.07-0.4-0.14
Retained Earnings
-442.38-430.03-384.18-339.54-298.1-259.81
Shareholders' Equity
34.7145.3982.9569.74106.34140.42
Total Liabilities & Equity
49.1761.8897.1981.64116.19149.54
Total Debt
0.650.831.522.152.723.12
Net Cash (Debt)
45.4157.4790.2272.67102.55137.7
Net Cash Growth
-20.99%-36.30%24.15%-29.13%-25.53%5.83%
Net Cash Per Share
0.680.861.891.632.353.53
Book Value
34.7145.3982.9569.74106.34140.42
Book Value Per Share
0.520.681.741.562.443.60
Tangible Book Value
34.7145.3982.9569.74106.34140.42
Tangible Book Value Per Share
0.520.681.741.562.443.60
Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q